Role of ECCO in the development of personalised oncology treatment

Bookmark and Share
Published: 22 Oct 2012
Views: 3945
Kathy Oliver – ECCO Patient Advisory Committee; Prof Julio Celis – ECCO Policy Committee; Prof Cornelis van de Velde – President of ECCO

The panel discuss the level of understanding of personalised oncology treatments among the general public and explain what steps must be taken to improve this.


There are many advantages to a more individualised approach to oncology; however for this approach to succeed it is essential that all stakeholders are engaged and contribute towards its development.


The panel explain how Horizon 2020 will give oncologists an opportunity to contribute to funding policy, consider the need for more advanced data management systems to deal with the increase in data associated with a multidisciplinary approach to oncology and emphasise the need for a platform for Europe-wide treatment guidelines.